Is Merck & Co. Stock Worth Buying Before the End of 2022? Healthcare company Merck & Co. (MRK) is set to acquire Imago BioSciences (IMGO) for more than $1 billion. The stock has gained more than 40% this year. However, given the… Previous Article Can I Apply for Supplemental Security Income Online? Next Article Yes, You Are Getting Scammed. How to Combat Fraud and Increase Efficiency
